Literature DB >> 35018970

Effectiveness of telemedicine in response to the COVID-19 pandemic.

Maria Angela de Souza1, Audrey Cristina Fioretti1, Aparecida Helena Vincentin1, Ricardo Vieira Botelho1, Cidia Vasconcellos1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the utility of the telemedicine care model implemented to treat and guide patients with COVID-19 related symptoms and indicators during the pandemic.
METHODS: This is a retrospective study with data collected from the electronic records of standardized forms for assistance. As a way of evaluating the work performed, the number of consultations, types of referrals, efficiency of care, and patient satisfaction were observed.
RESULTS: Between April 2 and October 15, 2020, 92 professionals attended 3,660 patients by telemedicine; out of them, 523 (14.3%) were referred to a COVID-19 attending room, 128 (3.5%) to other specialties, 123 (3.4%) to a general emergency department, and 2,886 (78.9%) were monitored via home care. Of the total number of patients, 81 (2.2%) were hospitalized, and 13 (0.35%) died.
CONCLUSION: Telemedicine offered useful tools for the care, treatment, and monitoring of patients with COVID-19 during the pandemic. The service was considered by most respondents as satisfactory, resolutive, or safe.

Entities:  

Mesh:

Year:  2021        PMID: 35018970     DOI: 10.1590/1806-9282.20210611

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

1.  Orthopedic Telemedicine Outpatient Practice Diagnoses Set during the First COVID-19 Pandemic Lockdown-Individual Observation.

Authors:  Wojciech Michał Glinkowski
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

2.  The COVID-19 Pandemic as an Impulse for the Development of Telemedicine in Primary Care in Poland.

Authors:  Kamila Furlepa; Andrzej Śliwczyński; Karolina Kamecka; Remigiusz Kozłowski; Izabela Gołębiak; Dominika Cichońska-Rzeźnicka; Michał Marczak; Wojciech Michał Glinkowski
Journal:  J Pers Med       Date:  2022-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.